Albumin-bound paclitaxel (Abraxane) for advanced breast cancer.
A new formulation that should be safer and easier to administer than Taxol.
D000068196:Albumin-Bound Paclitaxel; D000418:Albumins / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000556:secondary; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000209:etiology; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D017239:Paclitaxel / Q000009:adverse effects / Q000627:therapeutic use*; D011208:Powders / Q000008:administration & dosage / Q000191:economics
D000068196:Albumin-Bound Paclitaxel; D000418:Albumins; D011208:Powders; D017239:Paclitaxel